3DPrint.com July 27, 2023
A new international consortium called HU3DINKS is rallying behind a single mission: to develop advanced human tissue-based bioinks for 3D bioprinting. Supported by IraSME, a German network of funding programs; FFG, Austria’s national funding agency for industrial research and development; and VLAIO, the Flemish agency for innovation and entrepreneurship, the consortium seeks to replace synthetic and animal-derived bioinks, aiming to lead in the bioprinting revolution.
Many bioinks used in bioprinting come from non-human sources, with collagen and gelatin, both animal-derived, being popular choices. While these materials are biocompatible, they have limitations. For instance, the complex mixture of human tissue, including the extracellular matrix (ECM), glycosaminoglycans, or polysaccharides, is hard to replicate.
In its project database, HU3DINKS states that Matrigel, a...
Today's Sponsors
Today's Sponsor